Erratum to: A ‘Global Reference’ Comparator for Biosimilar Development

Erratum to: A ‘Global Reference’ Comparator for Biosimilar Development BioDrugs (2017) 31:287 DOI 10.1007/s40259-017-0236-3 ERRATUM Erratum to: A ‘Global Reference’ Comparator for Biosimilar Development 1 2 Christopher J. Webster Gillian R. Woollett Published online: 2 August 2017 Springer International Publishing AG 2017 Erratum to: BioDrugs DOI 10.1007/s40259-017-0227-4 The article ‘‘A ‘Global Reference’ Comparator for Biosim- ilar Development’’, written by Christopher J. Webster and Gillian R. Woollett, was originally published electronically on the publisher’s internet portal SpringerLink on 19 May 2017 without open access. With the authors’ decision to opt for Open Choice the copyright of the article changed on 01/08/2017 to  The Author(s) 2017 and the article is forthwith distributed under the terms of the Creative Com- mons Attribution-Non Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any non-commercial use, duplication, adap- tation, distribution and reproduction in any medium or for- mat, as long as you give appropriate credit to the original authors and the source, provide a link to the Creative Com- mons license and indicate if changes were made. The open access fee was funded by Avalere Health. The original article was corrected. The online version of the original article can be found under doi:10.1007/s40259-017-0227-4. & Gillian R. Woollett gwoollett@avalere.com BioApprovals, Acton, MA 01720, USA FDA Regulatory Strategy and Policy, Avalere Inc, 1350 Connecticut Avenue, NW, Suite 900, Washington, DC 20036, USA http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png BioDrugs Springer Journals

Erratum to: A ‘Global Reference’ Comparator for Biosimilar Development

Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/erratum-to-a-global-reference-comparator-for-biosimilar-development-dJBrFPbqg9
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Biomedicine; Molecular Medicine; Antibodies; Cancer Research; Pharmacotherapy
ISSN
1173-8804
eISSN
1179-190X
D.O.I.
10.1007/s40259-017-0236-3
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial